Viatris (VTRS) financial statements

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $19.0B

Viatris reported revenue of $14.3B in fiscal 2025, up 3.4% a year over 7 years.

Net income was -$3.5B and the operating margin -18.7%, against 8.0% in 2018.

Free cash flow was $1.9B, and the company returned $500M in net buybacks.

The diluted share count rose 134% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

0510152020182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Viatris's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Revenue$11.3B$11.4B$11.8B$17.8B$16.2B$15.4B$14.7B$14.3B
Cost of revenue$7.4B$7.6B$8.1B$12.3B$9.8B$9.0B$9.1B$9.3B
Gross profit$4.0B$3.9B$3.8B$5.6B$6.5B$6.4B$5.6B$5.0B
Research and development$704M$640M$555M$751M$662M$805M$809M$966M
Selling, general and admin$2.4B$2.6B$3.3B$4.5B$4.2B$4.1B$4.1B$3.8B
Operating income$906M$716M-$211M-$34M$1.6B$766M$10M-$2.7B
Interest expense$542M$517M$498M$636M$592M$573M$550M$471M
Pre-tax income$298M$154M-$721M-$664M$2.8B$203M-$623M-$3.7B
Income tax-$54M$138M-$51M$605M$735M$148M$11M-$150M
Net income$352M$17M-$670M-$1.3B$2.1B$55M-$634M-$3.5B
EPS (diluted)$0.68$0.03-$1.11-$1.05$1.71$0.05-$0.53-$3.00
Diluted shares516M516M601M1.21B1.22B1.21B——
Gross margin35.5%34.3%32.1%31.3%40.1%41.8%38.3%35.2%
Operating margin8.0%6.3%-1.8%-0.2%10.0%5.0%0.1%-18.7%
Net margin3.1%0.1%-5.7%-7.1%12.8%0.4%-4.3%-24.7%

Balance sheet

Fiscal years, from Viatris's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Cash and short-term investments$388M$502M$884M$739M$1.3B$1.0B$773M$1.4B
Receivables—$3.1B$4.8B$4.3B$3.8B$3.7B$3.2B$3.0B
Inventory—$2.7B$5.5B$4.0B$3.5B$3.5B$3.9B$4.0B
Total current assets—$6.8B$12.9B$10.9B$10.6B$13.0B$9.5B$9.8B
Property, plant and equipment—$2.1B$3.5B$3.2B$3.0B$2.8B$2.7B$2.6B
Goodwill$9.7B$9.6B$12.3B$12.1B$10.4B$9.9B$9.1B$6.8B
Total assets—$31.3B$61.6B$54.8B$50.0B$47.7B$41.5B$37.2B
Total current liabilities—$5.6B$10.6B$9.9B$6.7B$7.8B$5.8B$7.1B
Long-term debt—$11.2B$22.4B$19.7B$18.0B$16.2B$14.0B$12.5B
Total liabilities—$19.4B$38.6B$34.4B$28.9B$27.2B$22.9B$22.5B
Shareholders' equity$12.2B$0$23.0B$20.5B$21.1B$20.5B$18.6B$14.7B
Net debt-$388M$12.2B$23.9B$20.9B$18.0B$17.1B$13.3B$13.1B

Cash flow

Fiscal years, from Viatris's 10-K filings with the SEC.

Fiscal year20182019202020212022202320242025
Operating cash flow$2.3B$1.8B$1.2B$3.0B$3.0B$2.9B$2.3B$2.3B
Capital spending$252M$213M$243M$457M$406M$377M$326M$379M
Free cash flow$2.1B$1.6B$989M$2.6B$2.6B$2.5B$2.0B$1.9B
Stock-based compensation-$3M$57M$79M$111M$116M$181M$146M$178M
Share buybacks (net)-$432M$0$0$0$0-$250M-$250M-$500M
Net borrowing-$632M-$1.1B-$401M-$2.1B-$3.3B-$1.2B-$3.7B$100,000
Free cash flow margin18.5%14.0%8.4%14.4%16.0%16.4%13.5%13.6%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for VTRS.
Open VTRS in Investingly

Questions

What was Viatris's revenue in 2025?

$14.3B in fiscal 2025, from its 10-K filing.

How much free cash flow does Viatris generate?

$1.9B in fiscal 2025 (operating cash flow minus capital spending).

From Viatris's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.